Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2238-2248

  Nakae, Susumu ^a   Suto, Hajime ^a,b   Iikura, Motoyasu ^a   Kakurai, Maki ^a   Sedgwick, Jonathon D ^c,d   Tsai, Mindy ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; BINDING PROTEIN; CD134 ANTIGEN; CD137 LIGAND; CD153 ANTIGEN; FAS ANTIGEN; FC RECEPTOR EPSILON I; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; ICOS LIGAND; IMMUNOGLOBULIN E; NEUTRALIZING ANTIBODY; OX40 LIGAND; PROTEIN PD L1; PROTEIN PD L2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

EID: 32044471903     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2238     Document Type: Article

References (51)

1. Metcalfe, D. D., D. Baram, and Y. A. Mekori. 1997. Mast cells. Physiol. Rev. 77: 1033-1079.
2. Turner, H., and J. P. Kinet. 1999. Signalling through the high-affinity IgE receptor FcεRI. Nature 402: B24-B30.
3. Rivera, J. 2002. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol. 14: 688-693.
4. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799.
5. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
6. Bryce, P. J., M. L. Miller, I. Miyajima, M. Tsai, S. J. Galli, and H. C. Oettgen. 2004. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20: 381-392.
7. Jawdat, D. M., E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall. 2004. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173: 5275-5282.
8. Eager, K. B., C. J. Hackett, W. U. Gerhard, J. Bennink, L. C. Eisenlohr, J. Yewdell, and R. P. Ricciardi. 1989. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes. J. Immunol. 143: 2328-2335.
9. Frandji, P., C. Oskeritzian, F. Cacaraci, J. Lapeyre, R. Peronet, B. David, J. G. Guillet, and S. Mecheri. 1993. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151: 6318-6328.
10. Fox, C. C., S. D. Jewell, and C. C. Whitacre. 1994. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell. Immunol. 158: 253-264.
11. + T lymphocytes. Eur. J. Immunol. 26: 2517-2528.
12. Bhattacharyya, S. P., I. Drucker, T. Reshef, A. S. Kirshenbaum, D. D. Metcalfe, and Y. A. Mekori. 1998. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J. Leukocyte Biol. 63: 337-341.
13. Frandji, P., W. Mourad, C. Tkaczyk, M. Singer, B. David, J. H. Colle, and S. Mecheri. 1998. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway. Eur. J. Immunol. 28: 844-854.
14. Inamura, N., Y. A. Mekori, S. P. Bhattacharyya, P. J. Bianchine, and D. D. Metcalfe. 1998. Induction and enhancement of FcεRI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol. 160: 4026-4033.
15. Baram, D., G. G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y. A. Mekori. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J. Immunol. 167: 4008-4016.
16. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346: 274-276.
17. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174: 103-107.
18. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. Palladino, Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151: 4637-4641.
19. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334: 1717-1725.
20. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
21. McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4: 1199-1205.
22. Sayama, K., M. Diehn, K. Matsuda, C. Lunderius, M. Tsai, S. Y. Tam, D. Botstein, P. O. Brown, and S. J. Galli. 2002. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 3: 5.
23. Nakajima, T., N. Inagaki, H. Tanaka, A. Tanaka, M. Yoshikawa, M. Tamari, K. Hasegawa, K. Matsumoto, H. Tachimoto, M. Ebisawa, et al. 2002. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor 1 cross-linking: an interspecies comparison. Blood 100: 3861-3868.
24. + T lymphocyte chemoattractant factor, IL-16. J. Immunol. 159: 2904-2910.
25. + T cells through production of leukotriene B4. Nat. Immunol. 4: 974-981.
26. Kashiwakura, J., H. Yokoi, H. Saito, and Y. Okayama. 2004. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173: 5247-5257.
27. Nakae, S., H. Suto, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2005. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 103: 6467-6472.
28. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27: 2600-2609.
29. Ruuls, S. R., R. M. Hoek, V. N. Ngo, T. McNeil, L. A. Lucian, M. J. Janatpour, H. Korner, H. Scheerens, E. M. Hessel, J. G. Cyster, et al. 2001. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15: 533-543.
30. Liu, F. T., J. W. Bohn, E. L. Ferry, H. Yamamoto, C. A. Molinaro, L. A. Sherman, N. R. Klinman, and D. H. Katz. 1980. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J. Immunol. 124: 2728-2737.
31. Malaviya, R., N. J. Twesten, E. A. Ross, S. N. Abraham, and J. D. Pfeifer. 1996. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156: 1490-1496.
32. Asai, K., J. Kitaura, Y. Kawakami, N. Yamagata, M. Tsai, D. P. Carbone, F. T. Liu, S. J. Galli, and T. Kawakami. 2001. Regulation of mast cell survival by IgE. Immunity 14: 791-800.
33. Kalesnikoff, J., M. Huber, V. Lam, J. E. Damen, J. Zhang, R. P. Siraganian, and G. Krystal. 2001. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14: 801-811.
34. Tashiro, M., Y. Kawakami, R. Abe, W. Han, D. Hata, K. Sugie, L. Yao, and T. Kawakami. 1997. Increased secretion of TNF-α by costimulation of mast cells via CD28 and FcεRI. J. Immunol. 158: 2382-2389.
35. Marietta, E. V., J. J. Weis, and J. H. Weis. 1997. CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi. J. Immunol. 159: 2840-2848.
36. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
37. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
38. Gauchat, J. F., S. Henchoz, G. Mazzei, J. P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo, J. Thompson, et al. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365: 340-343.
39. Pawankar, R., M. Okuda, H. Yssel, K. Okumura, and C. Ra. 1997. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99: 1492-1499.
40. Molin, D., M. Fischer, Z. Xiang, U. Larsson, I. Harvima, P. Venge, K. Nilsson, C. Sundstrom, G. Enblad, and G. Nilsson. 2001. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br. J. Haematol. 114: 616-623.
41. Nakae, S., M. Asano, R. Horai, N. Sakaguchi, and Y. Iwakura. 2001. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J. Immunol. 167: 90-97.
42. Dinarello, C. A. 2004. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10: 201-222.
43. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
44. Killar, L., J. White, R. Black, and J. Peschon. 1999. Adamalysins: a family of metzincins including TNF-α converting enzyme (TACE). Ann. NY Acad. Sci. 878: 442-452.
45. Swallow, M. M., J. J. Wallin, and W. C. Sha. 1999. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα. Immunity 11: 423-432.
46. Okazaki, T., Y. Iwai, and T. Honjo. 2002. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 14: 779-782.
47. Kanai, T., T. Totsuka, K. Uraushihara, S. Makita, T. Nakamura, K. Koganei, T. Fukushima, H. Akiba, H. Yagita, K. Okumura, et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163.
48. Tsai, M., J. Wedemeyer, S. Ganiatsas, S. Y. Tam, L. I. Zon, and S. J. Galli. 2000. In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc. Natl. Acad. Sci. USA 97: 9186-9190.
49. Lohning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
50. Moritz, D. R., H. R. Rodewald, J. Gheyselinck, and R. Klemenz. 1998. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 161: 4866-4874.
51. Pedotti, R., J. J. De Voss, L. Steinman, and S. J. Galli. 2003. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24: 479-484.